share_log

Regulus Therapeutics Q4 EPS $(0.40) Misses $(0.39) Estimate

Moomoo 24/7 ·  Mar 21 16:08

Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) by 2.56 percent. This is unchanged from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment